Today's Pre-Market Stock Movers: LCID, H, GRAB, OCUL and More

• $United Natural Foods (UNFI.US)$ +2.8%, $Grab Holdings (GRAB.US)$ +1.8% (guidance update), $Splunk (SPLK.US)$ +0.9% (reaffirms guidance; also CFO to depart co)

• $Ocular Therapeutix (OCUL.US)$ +11.4% (reports interim 7-month data from U.S. Phase 1 Clinical Trial of OTX-TKI for the Treatment of Wet AMD)

• $Symbotic (SYM.US)$ +8.4% (UNFI to roll out SYM's robotics automation at five distribution centers)

• $Tritium DCFC (DCFC.US)$ +8.2% (fast chargers are available for purchase by government entities through the U.S. General Services Administration's (GSA) five-year Blanket Purchase Agreement (BPA) dedicated to EV-related equipment)

• $Nautilus (NLS.US)$ +7.2% (announces strategic review)

• $United Natural Foods (UNFI.US)$ +4% (UNFI to roll out SYM's robotics automation at five distribution centers)

• $VAALCO Energy (EGY.US)$ +3.6% (Successful Drilling of North Tchibala 2H-ST Well and Provides Operational Update)

• $Scorpio Tankers (STNG.US)$ +3% (announces repurchase of 222396 shares in the open market)

• $Shoe Carnival (SCVL.US)$ +2.7% (CFO to retire)

• $Rio Tinto (RIO.US)$ +2.3% (to begin underground mining at Kennecott copper operations)

• $Hyatt Hotels (H.US)$ +4% (upgraded to Outperform from In-line at Evercore ISI)

• $Lucid Group (LCID.US)$ +3.2% (initiated with an Overweight at Cantor Fitzgerald)

• $Avidity Biosciences (RNA.US)$ -20.1% (announces FDA partial clinical hold on new participant enrollment in the Phase 1/2 MARINA clinical trial of AOC 1001)

• $Science Applications International (SAIC.US)$ -0.9% (awarded $757 mln firm-fixed-price U.S. Army contract)

• $CS Disco (LAW.US)$ -1.3% (downgraded to Hold from Buy at Loop Capital)